Work

Neoadjuvant enzalutamide and androgen deprivation therapy for high-risk prostate cancer: Early results from a feasibility trial.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.6_suppl.94

Authors: David James VanderWeele, Baris Turkbey, Fatima Karzai, Stephanie Harmon, Adam G. Sowalsky, Huihui Ye, Scott Wilkinson, Guinevere Chun, Samuel Gold, Peter A. Pinto, Peter L. Choyke, William L. Dahut

Institutions: University of Chicago Medical Center, National Institutes of Health, National Cancer Institute, Leidos Biomedical Research Inc. (United States), Beth Israel Deaconess Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789875639

Cites:

Cited by: 1

Related to: 10